Shore Capital Reiterates “Buy” Rating for Genus (LON:GNS)

Shore Capital restated their buy rating on shares of Genus (LON:GNS) in a research report report published on Wednesday, Marketbeat Ratings reports.

Genus Stock Performance

Shares of Genus stock opened at GBX 1,634 ($20.62) on Wednesday. The company has a debt-to-equity ratio of 53.54, a current ratio of 1.80 and a quick ratio of 1.08. The firm has a 50 day simple moving average of GBX 1,892.40 and a 200 day simple moving average of GBX 1,819.67. Genus has a fifty-two week low of GBX 1,478 ($18.65) and a fifty-two week high of GBX 2,378 ($30.01). The firm has a market cap of £1.07 billion, a P/E ratio of 13,616.67, a P/E/G ratio of 2.87 and a beta of 0.37.

Insider Transactions at Genus

In other news, insider Jorgen Kokke sold 2,186 shares of the firm’s stock in a transaction dated Monday, September 16th. The shares were sold at an average price of GBX 1,956 ($24.69), for a total value of £42,758.16 ($53,967.13). 0.75% of the stock is currently owned by corporate insiders.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.